Literature DB >> 10335394

Autoantigens produced in plants for oral tolerance therapy of autoimmune diseases.

S Ma1, A M Jevnikar.   

Abstract

Oral administration of protein antigens can induce antigen-specific immune hyporesponsiveness and may be useful in treating autoimmune diseases or preventing transplant rejection. However, the therapeutic value of oral tolerance may be limited when candidate autoantigens cannot be produced by conventional system in quantities sufficient for clinical studies. Plants may be ideally suited for this purpose, as they can produce hugh quantities of functional mammalian proteins at extremely competitive cost. Furthermore, transgenic food plants could provide a simple and direct method of autoantigen delivery for oral tolerance. Here we show that the diabetes-associated autoantigen glutamic acid decarboxylase (GAD) is efficiently expressed in both tobacco and potato plants, and that mice, when fed with fresh transgenic potato tubers, are fully protected from diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335394     DOI: 10.1007/978-1-4615-4729-7_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  Importance of gastrointestinal ingestion and macromolecular antigens in the vein for oral tolerance induction.

Authors:  Ayako Wakabayashi; Yoshihiro Kumagai; Eiji Watari; Masumi Shimizu; Masanori Utsuyama; Katsuiku Hirokawa; Hidemi Takahashi
Journal:  Immunology       Date:  2006-06-23       Impact factor: 7.397

2.  Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats.

Authors:  Kaja Kasarello; Barbara Kwiatkowska-Patzer; Andrzej W Lipkowski; Jacek K Bardowski; Agnieszka K Szczepankowska
Journal:  Med Sci Monit       Date:  2015-05-31

3.  Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes.

Authors:  Baoping Liu; Yuan Yue; Yun Yang; Yongfeng Jin
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.